 |
| Companies in the park |
|
 |
|
Biognosis
Biognosis is a biotechnology-based company dedicated to the development, manufacture and sales of products for human and veterinary laboratorial diagnosis. This company, formed in 2005, searches for useful, relevant, simple and practical solutions for the laboratorial activity in a perspective of struggle against endemic diseases in Portugal and the world. |
|
 |
|
Biocant Ventures
Biocant Ventures was formed in 2006 and aims the investment in projects in the Life Sciences by financing the initial stages of projects until they develop into companies, assuming the role of business angels. This a pioneer initiative and of great structural relevance for the Portuguese biotechnology allowing that the ideas of young entrepreneurs have a reference of financial support to innovation, not available till today in our country. |
|
 |
|
Crioestaminal – Saúde e Tecnologia, SA
Crioestaminal is the first biotechnology company in Portugal dedicated to the isolation and criopreservation of stem cells from umbilical cord aiming their posterior use in the treatment of several diseases of the newly born and their family. The company, settled in 2003, is also developing research projects to increase the range of therapeutic applications of stem cells.
http://www.crioestaminal.pt |
|
 |
|
geneBOX
geneBOX, funded in May 2003 is a company for the conception, development and production of diagnostic tests oriented to molecular biology laboratories (either research or analysis), aiming to contribute to the progress of diagnostics and research in Health by supplying products of excellent quality and advanced technology.
http://www.genebox.com |
|
 |
|
GeneLab
GeneLab is a company that provides molecular diagnostics tests in genetics, oncology and infectious diseases. The laboratory is prepared to fulfil the needs of medical-hospital community, offering molecular tests based in nucleic acids (RNA or DNA) performed with state of the art technology such as quantitative analysis by real-time amplification of nucleic acids or microchips.
www.genelab.pt |
|
 |
|
Gene PreDiT, Lda.
Gene PreDiT is a biotechnology company launched in 2006 focused in the development of innovative strategies to identify novel biomarkers and novel applications of pharmaceutical compounds for diseases with high incidence worldwide. Our strategy is based on the in silico and in vivo comparison between the genomes of different organisms. Using several genetic and molecular tools, Gene PreDiT is able to identify which genes modulate some characteristic parameters associated to a certain disease, as well as the pharmaceutical compounds that affect those parameters. By developing methods and protocols that increase the quality and efficiency of the medical services leading to an increase in the quality of life of the individual, Gene PreDiT wants to contribute to a better understanding of human pathologies. |
|
 |
|
Haloris
Haloris Nanotechnologies works in the development and prototyping of portable biosensors to the sectors of health, food and agriculture. The company also offers consultancy in biosensors, biochemical functionalization of surfaces and development of biological tests. |
|
 |
|
Hematos - Saúde e Tecnologia, Lda
Founded in 2004, the Hematos.com was established to distribute medical devices to diagnosis in vitro in the genecology, cardiology and gastroenterology areas. Hematos.com is focus in diffusing and commercializing new diagnosis ways. |
|
 |
|
Novexem Portugal Lda.
Novexem is an international CRO (Contract Research Organization) specialized in the management and conduct of clinical trials and medico-marketing projects.
Equipped with highly qualified staff and covering many clinical areas, Novexem is capable of accomplishing tasks of varying duration and complexity in the majority of the European countries. On top of this, Novexem is able to place trials in India, Hungary, Latin-America and the US through partner companies.
http://www.novexem.com |
|
 |
|
Vectorpharma
Vectorpharma is a biotechnology start-up dedicated to the development of new nanotechnology-based application in diagnostics and therapeutics of cancer and neurodegenerative diseases. The company also provides services to pharmaceutical companies in the evaluation of activity, pharmacokinetics and biodistribution of new drugs, as well as the study of their mechanisms of action, using cellular and animal models of cancer and neurodegenerative diseases. |
|
| Park affiliates |
|
 |
|
4Health, Lda.
4Health, Lda - Consulting company in the health field with the emphasis of its activities focused towards Pharmacometrics (study design, data managament, data analysis and scientific reports). |
|
 |
|
Bioalvo, SA
BIOALVO is specialized in the research lead drug discovery process and in the early preclinical phase of the drug development process. BIOALVO’s main strategy is to develop projects from the exploratory research phase until the end of the preclinical stage. After successful completion of this phase, the products are out-licensed or co-developed to/with other larger biopharma companies for further pipeline development. Their expertise in the molecular field and an entirely new discovery strategy and technological approach allow this company to offer services at these specific phases of the drug development and production process and contributes to a growing innovative and proprietary IP portpholio. Their new and effective drug development programmes aim at combating severe Central Nervous System (CNS) and other neurodegenerative disorders.
http://www.bioalvo.com |
|
